Keybanc Maintains Overweight on BKV, Raises Price Target to $35

BKV Corporation +1.95%

BKV Corporation

BKV

28.18

+1.95%

Keybanc analyst Tim Rezvan maintains BKV (NYSE: BKV) with a Overweight and raises the price target from $34 to $35.